21 November 2017
Valneva SE, a fully integrated, commercial stage bioteh company focused on developing innovative, lifesaving vaccines, announces today the signing of a 39.6$ million one year contract with the US Government’s Department of Defense for supply of its Japanese encephalitis signed with the US military in March 2016 as the maximum quantity of doses allowed in the precedent contract was reached earlier than expected.
Under the terms of the new agreement, Valneva will supply the IXIARO® doses to the Defense Logistics Agency (DLA), Supply Center of the US Department of Defense, over a one-year period for a value of $28.2 million guaranteed and up to $39.6 million. First deliveries are expected to commence in the coming weeks.